drugset / Trial / NCT06534697

Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty

NCT06534697 ↗

Not yet recruiting 210 enrolled Foisor Orthopedics Clinical Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial aims to assess the analgesic efficacy of ultrasound-guided FIB using different analgesic combinations administered into the iliac fascia compartment. The main question it aims to answer is: ·What is the total morphine (mg) consumption at 24 hours postoperatively for each of the three groups? The secondary questions are: * What is the length of stay in hospital for each group? * What is the risk of falling associated with the use of fascia iliaca block? Researchers will compare two analgesic combinations of local anesthestic naropin 0,25% versus dextrose 10% administered by fascia iliaca block for postoperative pain after total hip arthroplasty.

Timeline

Start
2024-07-22
Primary completion
2024-12-30
Completion
2025-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.25 % Other
Comparator Ropivacaine Other / unclassified 40 ml Other

Indications